Submitted by Anonymous (not verified) on 4 September 2025 - 14:08
Human medicines European public assessment report (EPAR): Beyonttra, acoramidis, Date of authorisation: 10/02/2025, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Beyonttra, acoramidis, Date of authorisation: 10/02/2025, Revision: 2, Status: Authorised